This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

IHC Forum features workshop on pre-analytical considerations for targeted next generation sequencing for solid tumors
NSH
Next generation sequencing platforms have been developed to provide applications for clinical sequencing of solid tumors. The management of individual cancer patients is increasingly influenced by specific genetic features of the tumor. The genetic alterations of the solid tumor have the potential to drive therapeutic decisions for individual patients therefore appropriate processes must be implemented to provide reliable, accurate and timely results. Join us in Tennessee for the eighth annual IHC Forum where this session will focus on the pre-analytical consideration of NGS targeted applications for solid tumors, including specimen selection and identification, fixation, processing, specimen receipt, nucleic acid extraction and selection of the assay. Learn more.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




NSH webinar June 24, 1-2 p.m. EDT — Ophthalmology for the Histotechnologist
NSH
Presented by Robert Folberg, M.D., Oakland University William Beaumont School of Medicine
Ophthalmic pathology is an extremely interesting and unique field. During this presentation, we will review basic ocular anatomy and explore histologic and immunohistochemical techniques employed in the diagnosis of ocular disease. Basic fixation and processing for eyes will be discussed as well as routine and special stains. Problem solving strategies will be interjected along the way. Register now.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Submit now! Scientific Poster deadline is Friday June 19
NSH
Submit a Scientific Poster for the 41st Annual NSH Symposium/Convention. Poster presenters are eligible to earn three contact hours for their submission. For information on poster guidelines, click here. Poster applications must be submitted online and include title, authors and an abstract. Click here to submit your poster today!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


NSH hot topic webinar — 'Why Do My Medications Cost So Much?'
NSH
1 p.m. EDT, July 9
Nigel Edgerton, research lab supervisor of Pathology, Necropsy & Histology Department, The Hamner Institutes for Health Sciences, will cover the steps and the cost involved in bringing a drug to the pharmacy. Tips on how you can save money on your prescription drugs will be addressed. Finally and most important, we will look at things you can do to choose wellness over sickness. Register now.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Participate in ASCP 2015 wage survey
American Society for Clinical Pathology
The ASCP is conducting its wage survey of laboratory professionals in the field. The wage survey will remain open until midnight PDT, June 28.

As always, the ASCP has taken special measures to ensure survey takers privacy and the privacy of your laboratory. All responses are strictly confidential. No individual level data will be revealed, and in the final survey report, all information will be aggregated. This survey takes approximately 15 minutes to complete. There is a "back" button at the bottom of the page which will allow you to go back to the previous question to change your answer if necessary. Click here to take the survey.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




TOP STORIES


NIH's drug lab is shut down after FDA finds quality failures
Bloomberg
A U.S.-run laboratory that makes drugs for the National Institutes of Health's clinical trials failed a government quality inspection and will be temporarily shut down. The U.S. Food and Drug Administration, the government regulator that spends much of its time making sure drug companies follow exacting quality standards, inspected the NIH's Pharmaceutical Development Section. The lab makes drugs that are used in government-sponsored clinical trials at the NIH hospital in Bethesda, Maryland. Operations at the lab have been suspended.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Scientists identify protein that sustains heart function into old age
Johns Hopkins University School of Medicine via Medical Xpress
The human heart makes precious few new cells but manages to generate billions of life-sustaining beats as it grows old. Now research conducted in fruit flies, rats and monkeys by scientists at Johns Hopkins, UC San Diego, and other institutions reveals that levels of a protein called vinculin increase with age to alter the shape and performance of cardiac muscle cells — a healthy adaptive change that helps sustain heart muscle vitality over many decades.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Hassle Free Block Storage Cabinet

Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
 


Behavior matters: Redesigning the clinical trial
Drug Discovery & Development
When a new type of drug or therapy is discovered, double-blind randomized controlled trials are the gold standard for evaluating them. These trials, which have been used for years, were designed to determine the true efficacy of a treatment free from patient or doctor bias, but they do not factor in the effects that patient behaviors, such as diet and lifestyle choices, can have on the tested treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.


Ethics vs economics: The cost of outsourcing clinical trials to developing countries
The Conversation
As the death toll from the African Ebola crisis peaked, World Health Organization Director-General Margaret Chan delivered a scathing attack on the "profit-driven" pharmaceutical industry and its unwillingness to develop a vaccine "for markets that cannot pay." Chan's criticism challenged the notion that medical research is guided by a beneficent hand — an honorable impulse for the betterment of humanity. In reality, research and development of drugs is driven by markets rather than moral concern.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




IN THE NEWS


New imaging technique could make brain tumor removal safer, more effective, study suggests
Johns Hopkins University School of Medicine via Medical Xpress
Brain surgery is famously difficult for good reason: When removing a tumor, for example, neurosurgeons walk a tightrope as they try to take out as much of the cancer as possible while keeping crucial brain tissue intact — and visually distinguishing the two is often impossible. Now Johns Hopkins researchers report they have developed an imaging technology that could provide surgeons with a color-coded map of a patient's brain showing which areas are and are not cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Organ-rejection drugs may help prevent Alzheimer's disease
By Chelsea Adams
The calcineurin inhibitors that organ transplant patients take to prevent rejection may also work to prevent Alzheimer's disease. A new study examined the rate of Alzheimer's disease among 2,600 organ transplant patients. Results were compared with a 2014 national dataset from the Alzheimer's Association. Regardless of patients' age or which calcinerurin inhibitor they took, the organ recipients were far less likely to develop Alzheimer's disease than the general public.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Because of sizeable deductibles, more patients owe more money to clinical pathology labs, spurring labs to get smarter about collecting from patients
Dark Daily
In today's clinical laboratory marketplace, competency in revenue management is becoming just as important as clinical excellence. Blame it on these multi-year trends: shrinking lab budgets, Medicare price cuts and payers excluding labs from narrow networks. At the dawn of this decade — just five years ago — few pathologists and clinical lab executives would have predicted that the financial survival of their lab organizations would depend upon becoming more proficient and more sophisticated with billing and collections. Yet this is now a necessary response to the year-over-year decline in lab prices and revenue experienced since 2010.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Extreme 'preemie' infants at no higher risk if included in clinical trials
HealthDay
Extremely premature infants who take part in randomized clinical trials don't have worse outcomes while in the hospital compared to those who aren't part of such research, a new study finds. The researchers undertook the study because it wasn't known if taking part in randomized clinical trials posed a risk to extremely premature infants.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Choosing telehealth for growth: Evaluating logistics and operations
By Karen R. Thomas
One of the first steps toward choosing the right telehealth program for your business is to determine the needs of your customers, clients and/or patients so you can assess how telehealth will help them achieve better health outcomes. However, an equally important step in choosing the right telehealth program is to evaluate the logistics that will be required. Here are some important considerations when planning to add telehealth to your business.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The introverted manager
Lab Manager
If you are a lab manager, there is a good chance that you are an introvert, and there is a good chance that management may not view your introverted tendencies as positive contributors to your management skills. You may feel pressured to fit in, and you learn quickly that it pays to conform and act extroverted. However, no matter how hard you try to act extroverted, you may still end up facing challenges stemming from your introverted tendencies. Here is a road map that you can follow to utilize your introverted tendencies to thrive in an extroverted business world.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    New Alzheimer disease study makes connection to cause (The Huffington Post)
How wearable electronics will change clinical trials (Clinical Leader)
Scientists find CJD resistance gene (BBC)
Safer science (Lab Manager)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
June 10, 2015
June 3, 2015
May 28, 2015 blast
May 27, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063